| Property | Value |
|
has major subject area list
|
Adverse Drug Reaction Reporting Systems; Aminoglycosides; Antibodies, Monoclonal, Humanized; Clinical Trials as Topic; Leukemia, Myeloid, Acute
|
|
has minor subject area list
|
Antineoplastic Combined Chemotherapy Protocols; Child; Electronic Health Records; Female; Gemtuzumab; Humans; Male; Randomized Controlled Trials as Topic
|
|
information resource reference
|
Miller TP, Li Y, Kavcic M, Troxel AB, Huang YS, Sung L, Alonzo TA, Gerbing R, Hall M, Daves MH, Horton TM, Pulsipher MA, Pollard JA, Bagatell R, Seif AE, Fisher BT, Luger S, Gamis AS, Adamson PC, Aplenc R. Accuracy of Adverse Event Ascertainment in Clinical Trials for Pediatric Acute Myeloid Leukemia. J Clin Oncol. 2016 05 01; 34(13):1537-43.
|
|
label
|
Accuracy of Adverse Event Ascertainment in Clinical Trials for Pediatric Acute Myeloid Leukemia.
|